18 liver

92
Chapter Chapter 18 18 LIVER LIVER & & BILIARY TRACT BILIARY TRACT

Transcript of 18 liver

Page 1: 18 liver

Chapter 18Chapter 18LIVERLIVER

&&

BILIARY TRACTBILIARY TRACT

Page 2: 18 liver
Page 3: 18 liver
Page 4: 18 liver
Page 5: 18 liver

DUCT

SYSTEM

Page 6: 18 liver
Page 7: 18 liver
Page 8: 18 liver

N

OFIBROUS

TISSUE

Page 9: 18 liver
Page 10: 18 liver
Page 11: 18 liver

PORTAL

“TRIAD”

CENTRAL

VEIN

Page 12: 18 liver
Page 13: 18 liver
Page 14: 18 liver

PATTERNS OF HEPATIC INJURY

• Degeneration:– Balooning, “feathery” degeneration, fat,

pigment

• Inflammation: Viral or Toxic– Regeneration

– Fibrosis

• Neoplasia: 99% metastatic, 1% primary

Page 15: 18 liver

BALOONING DEGENERATION

Page 16: 18 liver

“FEATHERY” DEGENERATION

Page 17: 18 liver

FATTY LIVER

Page 18: 18 liver

MICROVESICULAR STEATOSIS

Page 19: 18 liver

MACROVESICULAR STEATOSIS

Obesity

Diabetes

Toxic

Page 20: 18 liver

“Golden” pigment stained with Prussian Blue stain to make it blue. Hemosiderin? Bile? Melanin?

Page 21: 18 liver
Page 22: 18 liver

APOPTOSIS

Page 23: 18 liver

INFLAMMATION•PORTAL TRIADS

(early)

•SINUSOIDS(more severe)

Page 24: 18 liver

MILD TRIADITIS

Page 25: 18 liver

More severe portal infiltrates with sinusoidal infiltrates also

Page 26: 18 liver

Hepatic Regeneration

• The LIVER is classically cited as the most “REGENERATIVE” of all the organs!

Page 27: 18 liver

FIBROSIS• FIBROSIS is the end stage of

MOST chronic liver diseases, and is ONE (of TWO) absolute criteria needed for the diagnosis of cirrhosis.

• What is the other?

Page 28: 18 liver

CIRRHOSIS• PORTAL-to-PORTAL (bridging)

FIBROSIS• The “normal” hexagonal

“ARCHITECTURE” is

replaced by NODULES

Page 29: 18 liver

CIRRHOSIS• Liver

• Alcoholic

• Biliary (Primary or Secondary)

• Laennec’s

• Advanced

• Post-necrotic

• Micronodular

• Macronodular

Page 30: 18 liver

ALL CIRRHOSIS IS:• IRREVERSIBLE• The end stage of ALL chronic liver disease,

often many years, often several months

• Associated with a HUGE degree of nodular regeneration, and therefore represents a significant “risk” for primary liver neoplasm, i.e.,

“Hepatoma”, aka, Hepatocellular Carcinoma

Page 31: 18 liver

BLIND MAN’s LIVER

Page 32: 18 liver

Blind Man’s Diagnosis

Page 33: 18 liver
Page 34: 18 liver

N

OFIBROUS

TISSUE

Page 35: 18 liver

IRREGULAR NODULES SEPARATED BY PORTAL-to-PORTAL FIBROUS BANDS

Page 36: 18 liver

TRICHROME

Page 37: 18 liver

CIRRHOSIS, TRICHROME STAIN

Page 38: 18 liver

CIRRHOSIS, TRICHROME STAIN

Page 39: 18 liver

DEFINITIONS:• CIRRHOSIS is the name of

the disease as demonstrated by the anatomic changes

• LIVER FAILURE is the series and sequence of abnormal pathophysiologic events

Page 40: 18 liver
Page 41: 18 liver
Page 42: 18 liver

“SPIDER” ANGIOMA, CIRRHOSIS

Page 43: 18 liver

Common Clinical/Pathophysiological

Events• Portal Hypertension WHY? WHERE?

• Ascites WHY? (Heart/Renal?)

• Splenomegaly WHY?

• Jaundice WHY?

• “Estrogenic” effects WHY?

• Coagulopathies (II, VII, IX, X) WHY?

• Encephalopathy WHY?

Page 44: 18 liver

Hepatic Enzymology• Transaminases (AST/ALT), aka (SGOT/SGPT),

and LDH are “hepatic INTRACELLULAR” enzymes, and are primarilly indicative of hepatocyte damage.

• Alkaline Phosphatase (AlkPhos), Gamma-GTP (Gamma-glutamyl transpeptidase), and 5’-Nucleotidase (5’N) are MEMBRANE enzymes and are primarilly indicative of bile stasis/obstruction

Page 45: 18 liver

Intracellular = DAMAGEAST/ALT/LDH

Membrane = OBSTRUCTION

AlkPhos/GGTP/5’N

Page 46: 18 liver

JAUNDICE

Where else?

Page 47: 18 liver

Bilirubin: (0.3-1.2 mg/dl)

UN-conjugated (indirect)

Conjugated (direct)

Page 48: 18 liver

JAUNDICE• Hemolytic (UN-conjugated)

• Obstructive (Conjugated)

Page 49: 18 liver

JAUNDICE• Excessive production

• Reduced hepatic uptake

• Impaired Conjugation

• Defective Transportation

Page 50: 18 liver

Neonatal Jaundice• Neonatal, genetic

–Gilbert Syndrome

–Dubin-Johnson Syndrome

• Neonatal, NON-genetic–MASSIVE differential diagnosis, i.e.,

everything

Page 51: 18 liver

CHOLESTASIS• Def: Suppression of bile flow• Associated with membrane

enzyme elevations, “primarily”, ie, AP/GGTP/5’N

• Familial, drugs, but bottom line is OBSTRUCTION

Page 52: 18 liver
Page 53: 18 liver
Page 54: 18 liver

Bile “plugs”, Bile “lakes”

Page 55: 18 liver

VIRAL HEPATITIS• A, B, C, D, E• They all look the same, ranging from a

few extra portal triad lymphocytes, to “FULMINANT” hepatitis

• Associated with full recovery (usual), chronic progression over years leading to cirrhosis (not rare), risk of hepatoma (uncommon), or death (uncommon)

Page 56: 18 liver

VIRAL HEPATITIS• Jaundice, urine dark, stool chalky

• Viral “prodrome”

• Upper respiratory infection

• All have multiple antigen (virus) and antibody (serology) serum tests

• “Councilman” bodies on biopsy are very very nice to find. Why?

Page 57: 18 liver
Page 58: 18 liver

Chiefly Portal Inflammation

Page 59: 18 liver

FULMINANT HEPATITIS

Page 60: 18 liver

“FULMINANT” Acute Viral Hepatitis

Page 61: 18 liver

“Councilman” Bodies……Diagnostic? Probably!

Page 62: 18 liver

B

Page 63: 18 liver

CLESS common than B (one fourth)

LESS dangerous than B in the acute phase

MORE likely to go chronic than B

MORE closely linked with hepatoma than B

Page 64: 18 liver
Page 65: 18 liver

NON-Viral hepatitides• Staph aureus (toxic shock)

• Gram-Negatives (cholangitis)

• Parasitic:– Malaria– Schistosomes– Liver flukes (Fasciola hepatica)

• Ameba (abscesses)

• AUTOIMMUNE• ALCOHOLIC HEPATITIS

Page 66: 18 liver

DRUGS/TOXINS• Steatosis (ETOH)

• Centrolobular necrosis (TYLENOL)

• Diffuse (massive) necrosis

• Hepatitis

• Fibrosis/Cirrhosis (ETOH)

• Granulomas

• Cholestasis (BCPs, steroids)

Page 67: 18 liver

“Metabolic” Liver Disease• Steatosis (i.e., “fat”, fatty change,

fatty “metamorphosis”)• Hemochromatosis (vs. hemosiderosis)

–Hereditary (Primary)

–Iron Overload (Secondary), e.g., hemolysis, increased Fe intake, chronic liver disease

• Wilson Disease (Toxic copper levels)• Alpha-1-antitrypsin (NATURAL protease inhibitor)

• Neonatal Cholestasis

Page 68: 18 liver

PAS positive inclusions with alpha-1-antitrypsin deficiency

Page 69: 18 liver

INTRAHEPATIC

BILE DUCTS

Page 70: 18 liver

Points of Interest• INTRA-hepatic vs. EXTRA-hepatic• PRIMARY biliary cirrhosis is a bona-fide

AUTOIMMUNE disease of the INTRA-hepatic bile ducts

• SECONDARY biliary cirrhosis is caused by chronic obstruction/inflammation/both of the intrahepatic bile ducts

• CHOLANGITIS, or inflammation of the INTRA-hepatic bile ducts, is associated with chronic bacterial (often gram negative rods) infections, or Crohns/Ulcerative colitis (IBD)

Page 71: 18 liver

CIRCULATORY

Disorders

Page 72: 18 liver

Points of Interest• Infarcts are rare. WHY?

• Passive congestion with “centrolobular” necrosis, is EXTREMELY COMMON in CHF, and a VERY COMMON cause of cirrhosis, i.e., “cardiac” cirrhosis

• Various semi reliable clinical and anatomic findings are seen with disorders of:– Portal Veins– Hepatic veins/IVC– Hepatic arteries

Page 73: 18 liver

MISC.• Hepatic Diseases are seen often with

–Pregnancy• PRE-Eclampsia/Eclampsia (HTN, proteinuria,

edema, coagulopathies, DIC)• Fatty Liver• Cholestasis

–Transplant—Bone Marrow or other Organs

• Drug Toxicities• GVH

Page 74: 18 liver

BENIGN LIVER TUMORS• …..are, in most cases, really regenerative

nodules

• Have been historically linked to BCPs

• Can really be neoplasms of blood vessels also

Page 75: 18 liver

MALIGNANT LIVER TUMORS• 99% are metastatic, i.e., SECONDARY, esp. from

portal drained organs• Just about every malignancy will wind up

eventually in the liver, like the lungs

• PRIMARY liver malignancies, i.e., hepatomas, aka hepatocellular carcinomas, arise in the background of already very serious liver disease chronic hepatitis/cirrhosis, are slow growing, and do NOT metastasize readily

• CHOLANGIOCARCINOMAS are malignancies if the INTRA-hepatic bile ducts and look MUCH more like adenocarcinomas than do hepatomas

Page 76: 18 liver
Page 77: 18 liver

HEPATIC ANGIOMA

Page 78: 18 liver

HEPATOMA, or HEPATOCELLULAR

CARCINOMA

Page 79: 18 liver

CHOLANGIOCARCINOMA

Page 80: 18 liver

EXTRAHEPATICEXTRAHEPATICBILE DUCTSBILE DUCTS

&&GALLBLADDERGALLBLADDER

Page 81: 18 liver
Page 82: 18 liver

MAINCONSIDERATIONS

• Anomalies

• Stones (Clolesterol/Bilirubin)• (Chole[docho]lithiasis)• Inflammation

(Cholecystitis/Cholangitis)• Cysts• Neoplasms

Page 83: 18 liver

Anomalies• Congenitally absent

Gallbladder

• Duct Duplications

• Bilobed Gallbladder

• Phrygian Cap

• Hypoplasia/Agenesis

Page 84: 18 liver

Phrygian Cap

Page 85: 18 liver

CholelithiasisFactors

• Bile supersaturated with cholesterol

• Hypomotility

• Cholesterol “seeds” in bile, i.e., crystals

• Excess mucous in gallbladder

Page 86: 18 liver

Cholesterolosis of gallbladder mucosa

Page 87: 18 liver

Cholesterolosis of gallbladder mucosa

Page 88: 18 liver
Page 89: 18 liver
Page 90: 18 liver

Cholecystitis• Acute: fever, leukocytosis, RUQ pain• Chronic: Subclinical or pain• Ultrasound can detect stones well• HIDA (biliary) nuclear study can help

• Go hand in hand with stones in gallbladder or ducts

• If surgery is required, most is laparoscopic

Page 91: 18 liver

Choledochal Cysts

• Dilatations of the common bile duct usually in children.

Page 92: 18 liver

Adenocarcinoma of the gallbladder